Walvax Biotechnology Co., Ltd.
13价肺炎球菌多糖结合疫苗上市销售；2价HPV获得国家药品监督管理局出具的新药生产申请《受理通知书》；公司与军科院、艾博生物联合研发的新型冠状病毒mRNA疫苗进入Ⅰ期临床；公司与清华大学、天津医科大学合作研发的国内首个黑猩猩腺病毒载体新冠疫苗即将申报临床。 第一期员工持股计划实施;上海泽润与盖茨基金会签署《低成本HPV疫苗开发和世界卫生组织预认证》协议,获得了盖茨基金会500万美元的项目基金,用于加速HPV(16/18型)疫苗(酵母)的研发和产业化进度。 第一期员工持股计划实施;上海泽润与盖茨基金会签署《低成本HPV疫苗开发和世界卫生组织预认证》协议,获得了盖茨基金会500万美元的项目基金,用于加速HPV(16/18型)疫苗(酵母)的研发和产业化进度。 13价肺炎球菌多糖结合疫苗成功出口摩洛哥；2价HPV疫苗获批上市；公司高效推动多项战略型研发项目进程，特别在mRNA研发技术平台取得了里程碑式的成果，同时也体现公司始终坚定创新驱动的发展路径。 与军科院、艾博生物联合研发的国内首个新型冠状病毒mRNA疫苗开展海外III期临床试验；mRNA新冠疫苗模块化厂房投入使用，预计产能2亿剂/年。
Basic Information
- Category: company
- Website: http://www.walvax.com
Documented Facts
- Email: bd@walvax.com (No linked source recorded for this statement.)
Evidence and Sources
Citation Guidance
Explore company profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Walvax Biotechnology Co., Ltd..
- Canonical profile: https://brandsource.ai/brands/walvax-biotechnology-co-ltd
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/walvax-biotechnology-co-ltd/json-ld
- Citation profile API: https://brandsource.ai/api/brands/walvax-biotechnology-co-ltd/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Structured profile (59/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-21
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Walvax Biotechnology Co., Ltd. is listed in company on BrandSource.AI.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 1 structured fact available for extraction.
Known data gaps
- Needs a specific, non-thin summary
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.